Clinical trial
Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation…
NCT00050063 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00050063 |
|---|---|
| Title | Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs |
| Official title | A Rollover Study of A5058s: A Phase II Trial to Evaluate the Ability of Vaccine-Induced Helper and CTL Responses to Control Viremia in the Absence of Antiretroviral Therapy |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | Therapeutic vaccinations from A5058s |
| Enrollment | 78 |
| Completion | May 1, 2004 |
| First posted | Nov 21, 2002 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: